Related Experiment Video
Updated: Mar 29, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face?
Marco Barbanti1, Simona Gulino1, Corrado Tamburino1,2
1a Division of Cardiology-Ferrarotto Hospital , University of Catania , Catania , Italy.
Abstract:
The issue of stroke and bleeding events following transcatheter aortic valve implantation (TAVI) and its relation with antithrombotic regimens before, during and after the procedure is increasingly recognized as an important issue. While dedicated trials are ongoing, there is no clear evidence at present on the best antithrombotic regimen in the context of TAVI. In this article, we will go through the mechanisms involved in embolic and bleeding complications of TAVI, and we will discuss the key aspects of antithrombotic treatment in patients undergoing TAVI.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Aortic Regurgitation III: Medical Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Atherosclerosis III: Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Coronary Artery Disease V: Interprofessional Care

